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Modern biotechnology will not solve all the problems
of food insecurity and poverty. But it could provide a
key component to a solution if given the chance.
Today, almost a billion people live in absolute poverty and suffer from chronichunger. Seventy percent of these individuals are farmers—men, women, andchildren—who eke out a living from small plots of poor soils, mainly in trop-
ical environments that are increasingly prone to drought, flood, bushfires, and hur-
ricanes. Crop yields in these areas are stagnant and epidemics of pests and weeds
often ruin crops. Livestock suffer from parasitic diseases, some of which also affect
humans. Inputs such as chemical fertilizers and pesticides are expensive, and the lat-
ter can affect the health of farm families, destroy wildlife, and contaminate water
courses when used in excess. The only way families can grow more food and have
a surplus for sale seems to be to clear more forest. Older children move to the city,
where they, too, find it difficult to earn enough money to buy the food and medi-
cine they need for themselves and their young children.
As these detrimental social and environmental changes are occurring in the
developing world, a revolution in biotechnology and associated information tech-
nology is improving the health, well-being, and lifestyle of the privileged and cre-
ating more wealth in a few rich countries. Can this revolution also be harnessed to
serve the food and nutrition needs of the world’s poor? What are the opportunities,
problems, and risks involved with the new technologies and can they be managed?
The last question is particularly pressing in light of the current controversy between
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the United States and the European Union over genetically modified foods. The
benefits and risks of biotechnology weigh differently for food in areas of food sur-
plus than they do for life-threatening diseases in those same areas.
Opportunities
In 1998 the global market for biotechnology products (see box for definition of
terms) totaled at least US$13 billion. About 80 products, most of them medically
related, are on the market or nearly ready for it. In recent years, the fruits of two
decades of intensive and expensive research and development (R&D) in agricultural
biotechnology has begun to pay off. Approximately 28 million hectares of land were
planted with 40 transgenic crops in 1998. Most of these crops were new varieties
of cotton, corn, soybean, and rapeseed. Developing countries held 15 percent of the
area planted with the transgenic varieties.
Most biotechnology-based solutions for agriculture are likely to be delivered
in the form of new plant seeds or new strains of livestock. These solutions contin-
ue the tradition of selection and improvement of cultivated crops and livestock
developed over the centuries. The difference is that new gene technology identifies
desirable traits more quickly and accurately than conventional plant and livestock
breeding. Modern biotechnology can also introduce the genes that control desir-
able traits into plant and animal strains with far greater precision and control than
can conventional methods.
Biotechnology applications in agriculture are in their infancy. The first gener-
ation of genetically engineered plant varieties have been modified only for a single
trait, such as herbicide tolerance or pest resistance. The rapid progress being made
in genomics will transform plant, tree, and livestock breeding as the functions of
more genes are identified. Breeding for complex traits such as drought tolerance,
which is controlled by many genes, should then become common. This is an area
of great potential benefit for tropical crops, which are often grown in harsh envi-
ronments and on poor soils.
To determine if modern biotechnology can benefit the poor in developing
countries, policymakers at the national, regional, and international levels need to
analyze the problems that are currently constraining agricultural productivity or
damaging the environment, assess whether these problems may be solved by inte-
grating modern biotechnology with conventional R&D, and prioritize solutions.
This may seem self-evident, but such strategic analyses are indispensable for an-
ticipating the potential benefits and risks that may arise while using modern bio-
technology to solve specific problems. In addition to analyses, both public and
private resources for R&D need to be mobilized if the poor in developing coun-
tries are to profit from the genetic revolution.
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Policy Framework
Modern biotechnology will not solve all the problems of food insecurity and poverty.
But it could provide a key component to a solution if given the chance, and if steered
by a set of appropriate policies. These policies should guide (1) increased public
investments in R&D, including that in modern biotechnology; (2) regulatory
arrangements that inform and protect the public from any risks arising from the
release of genetically modified organisms (GMOs); (3) intellectual property man-
agement to encourage greater private-sector investment; and (4) regulation of the
private seed and agricultural research sector to protect the interests of small farm-
ers and poor consumers in developing countries.
Public-Sector R&D
Pro-poor policies can help expand agricultural R&D, including traditional and
modern biotechnological research, in order to solve problems of particular impor-
tance to the poor. The problems of orphan commodities (important subsistence food
and/or tropical export commodities that hold little commercial interest for the pri-
Definitions of Biotechnology and 
Its Component Technologies
Biotechnology is any technique that uses living organisms or substances from
those organisms to make or modify a product, improve plants or animals, or
develop microorganisms for specific uses. The key components of modern
biotechnology are
• Genomics: the molecular characterization of all species;
• Bioinfomatics: the assembly of data from genomic analysis into accessible
forms;
• Transformation: the introduction of single genes conferring potentially
useful traits into plant, livestock, fish, and tree species;
• Molecular breeding: the identification and evaluation of desirable traits in
breeding programs with the use of marker-assisted selection;
• Diagnostics: the use of molecular characterization to provide more accurate
and quicker identification of pathogens;
• Vaccine technology: use of modern immunology to develop recombinant
DNA vaccines for improving control of lethal diseases.
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vate sector) require particular attention. Given the high rates of return, more pub-
lic support for agricultural R&D should be encouraged in most developing coun-
tries. Additional public financial support for R&D at the national, regional, and
international levels would help to develop public goods the poor can afford.
Biosafety
The term biosafety describes a set of measures used to assess and manage any risks
associated with GMOs. Such risks may transcend or be inherent in the technology
and need to be managed accordingly. Technology-transcending risks emanate from
the political and social context in which the technology is used. They include con-
cerns that biotechnology may increase the prosperity gap between the rich and the
poor, and may contribute to a loss of biodiversity. Ethical concerns about patent-
ing living organisms and moving genes between species also fall into this category.
The principles and practices for assessing and managing technology-inherent
risks are well established in several countries. They take into account the nature of
the organism, the familiarity of the product, any distinguishing features of the
process by which a product was produced, and the environment into which it will
be introduced. A science-based assessment of these factors on a case by case basis,
and identification of any concerns expressed by stakeholders, enable regulators to
find out what risks may be associated with a particular product and to make appro-
priate recommendations. A regulatory system that enjoys the confidence of the pub-
lic and the business and farming communities is essential for the effective use of
biotechnology. The current and proposed international agreements that govern
movements of GMOs also contribute to biosafety.
Intellectual Property Management
The purpose of intellectual property management is to protect local inventions and
enable access to technologies developed elsewhere. Trade-related intellectual prop-
erty rights (TRIPs) are a matter of ongoing concern within the World Trade
Organization. The present patent system favors those countries that have a strong
innovation base. Despite much effort, no satisfactory system exists to recompense
traditional owners and improvers of germplasm. The lack of intellectual property
protection also constrains private-sector investment in developing countries.
The Private Sector
The participation of the private sector is critical to the development and delivery
of new biotechnology products. The enabling environment to encourage private-
sector participation includes a regulatory system that accurately informs the public
of the benefits and risks involved in the use of new technologies; a legal framework
for protecting intellectual property; adequate infrastructure for power, transport, and
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telecommunications; a fair tax system and investment incentives; a skilled workforce,
including a well-supported university sector; public funding for R&D; and incen-
tives to establish innovative public-private collaboration and joint ventures at the
national and international levels.
Delivering Solutions for the Poor
The successful application of modern biotechnology to the problems that cause
undernourishment and poverty could be called a biosolution. The delivery of new
biosolutions to the problems of food security and poverty will require continual pol-
icy development and actions at the national, regional, and international levels.
These efforts will involve the following five areas: (1) determining priorities and
assessing relative risks and benefits in consultation with the poor, who are often over-
looked while others decide what is best for them; (2) setting policies that benefit
the poor and that minimize technology-transcending risks that adversely affect the
poor; (3) establishing an environment that facilitates the safe use of biotechnology
through investment, regulation, intellectual property protection, and good gover-
nance; (4) actively linking biotechnology and information technology so that new
scientific discoveries worldwide can be assessed and applied to the problems of food
insecurity and poverty in a timely manner; and (5) determining what investments
governments and the international development community will have to make in
human and financial resources in order to ensure that biosolutions to the problems
of food security reach the poor.
